These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 887714)

  • 1. A comparison of drug-trial schizophrenics with their clinical counterparts.
    Guy W; Cleary P; Switalski R
    Psychopharmacol Bull; 1977 Jul; 13(3):44-5. PubMed ID: 887714
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical development of atypical antipsychotics: research design and evaluation. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():10-6. PubMed ID: 9766614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of evoked potentials on clinical symptoms and treatment efficiency in acute schizophrenics].
    Zhang MD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Jun; 21(3):178-82, 190. PubMed ID: 3229210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of Clozapol in the treatment of schizophrenia].
    Kiejna A; Borys J; Hein-Antonik K; Baranowski P
    Psychiatr Pol; 1993; 27(5):563-74. PubMed ID: 8255948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine in violent non-epileptic schizophrenics.
    Luchins DJ
    Psychopharmacol Bull; 1984; 20(3):569-71. PubMed ID: 6473664
    [No Abstract]   [Full Text] [Related]  

  • 7. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
    Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
    Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of neuroleptics on the frontal functions of schizophrenics].
    Verdoux H; Magnin E; Bourgeois M
    Ann Med Psychol (Paris); 1994 Oct; 152(8):530-4. PubMed ID: 7818228
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial of an acridane derivative (SKF No. 14,336) in male schizophrenics.
    Hekimian LJ; Floyd A; Gershon S
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):17-23. PubMed ID: 4963018
    [No Abstract]   [Full Text] [Related]  

  • 11. [Averaged voice spectra in schizophrenics--responders and nonresponders to neuroleptic drugs].
    Sváb L; Ganický P; Pasler A; Sedlácek K; Michek F; Vinar O
    Cesk Psychiatr; 1986 Apr; 82(2):123-6. PubMed ID: 3731308
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction: evaluating clinical trial data from schizophrenia research.
    Tamminga CA
    J Clin Psychiatry; 2001; 62 Suppl 9():3-4. PubMed ID: 11379829
    [No Abstract]   [Full Text] [Related]  

  • 13. A blind comparison of clozapine and perphenazine in schizophrenics.
    Rodová A; Svestka J; Náhunek K; Cesková E
    Act Nerv Super (Praha); 1973 May; 15(2):94-5. PubMed ID: 4752682
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects.
    Holden JM; Itil TM; Keskiner A
    J Clin Pharmacol J New Drugs; 1969; 9(3):163-75. PubMed ID: 5255181
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of indocyanine green in the assessment of liver function in schizophrenics].
    Badurski J; Makosa M; Sarosiek J; Tolwiński T
    Pol Tyg Lek; 1973 Jan; 28(4):118-20. PubMed ID: 4405675
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment.
    Hirayasu Y; Asato N; Ohta H; Hokama H; Arakaki H; Ogura C
    Biol Psychiatry; 1998 Feb; 43(4):244-53. PubMed ID: 9513733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Predicting the effects of haloperidol on schizophrenics by quantitative pharmaco-EEG].
    Zhang XL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):300-2, 318. PubMed ID: 1291253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial of thiothixene (Navane) in schizophrenics.
    Oliveros RF; Amin M; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1967 Oct; 9(10):504-7. PubMed ID: 4964944
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.